LIGAND PHARMACEUTICALS (LGND) Institutional Ownership and Insiders Activity

LIGAND PHARMACEUTICALS (LGND) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $369,510 based on SEC Form 13F filings for the quarter ended June 30, 2026.

Sequoia Financial Advisors is the largest disclosed holder, reporting approximately $369,510 in LGND holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Sequoia Financial Advisors representing the majority of disclosed value.

Recent insider activity includes 50 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.